Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT02776969

A Gene Hunting Study for Familial Papillary Thyroid Cancer

The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). Papillary thyroid cancer is a type of cancer that shows high heritability. However, the specific genetic factors that cause an increased risk have been elusive.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

About this study

The aim of this project is to identify genetic risk factors associated with familial papillary thyroid carcinoma (PTC). This can be accomplished in several ways, including loss of heterozygosity studies as well as comparative gene expression analysis. When possible, linkage analysis on families with multiple individuals affected with PTC may also help identify the putative gene(s).

Study participants will be asked to:

  • Complete family history and medical history questionnaires
  • Sign a medical record release so that thyroid cancer pathology reports can be obtained
  • Supply a blood or saliva sample for genetic studies
  • Provide study related information to family members who are needed for family studies

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a diagnosis of PTC and a family history of PTC in 3 or more living relatives
  • Affected and unaffected family members of the proband*
  • For familial cases (families with 4 or more cases of PTC), participation will be offered to all living family members with PTC or benign thyroid disease as well as selected unaffected first and second degree relatives. Participation may also be offered to spouses when needed for analyzing parent/offspring samples.

Exclusion criteria

  • Known germline predisposition (ex: pathogenic PTEN variant)
  • Non-English speaking

Treatment and study plan

Primary outcomes

  1. Genetic variants associated with familial papillary thyroid cancer as assessed by multiple genetic testing methodologies

    Time frame: Up to 5 years

    Variants will be assessed for segregation within families, expression in the normal thyroid and/or thyroid cancer, and functional significance

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

A Strategy to Search for Genes Predisposing to Papillary Carcinoma of the Thyroid When Mutated

Important dates

Study start
1998
Primary completion
2026
Study completion
2026
First posted
May 19, 2016
Registry last updated
Oct 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.